专利检索 ap:("BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.") AND inv:"Xiao LIU" 第 1 页

1.

发明公开
ANTI-FXI/FXIA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF 审中-公开

公开(公告)号：US20230220111A1

公开(公告)日：2023-07-13

申请号：US18013524

申请日：2021-07-02

申请人： BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.

发明人： Lei WANG , Xugang HE , Jin ZHANG , Xiao LIU , Dongmei HU , Yanping DU , Ran WU , Chenxi SHEN , Yang YANG , Changyong YANG

IPC分类号： C07K16/36 , A61P7/02

CPC分类号： C07K16/36 , A61P7/02 , A61K2039/505

摘要： Provided are an anti-FXI/FXIa antibody, an antigen-binding fragment thereof, and a pharmaceutical use thereof, as well as a pharmaceutical composition comprising the anti-FXI/FXIa antibody or the antigen-binding fragment thereof, and a method for treating and preventing a disease, in particular a method for treating thrombosis or thromboembolism-related diseases or disorders.